Global Endocrine Disruptor Testing Market Research Report 2024

Publication ID:

PB512249387

Publication Date:

December 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global market for Endocrine Disruptor Testing was valued at US$ 186 million in the year 2023 and is projected to reach a revised size of US$ 318 million by 2030, growing at a CAGR of 8.3% during the forecast period.
Endocrine Disruptor Testing refers to the process of evaluating substances to determine their potential to interfere with the endocrine (hormonal) system in humans and animals. These tests assess whether chemicals can mimic, block, or alter hormone functions, which can lead to adverse health effects such as developmental, reproductive, neurological, or immune system disruptions. The testing typically involves in vitro (cell-based), in vivo (animal), and computational models to identify endocrine activity, and is crucial for regulatory agencies to assess the safety of chemicals in pharmaceuticals, pesticides, and other consumer products.
North American market for Endocrine Disruptor Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Endocrine Disruptor Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Endocrine Disruptor Testing in Environmental Monitoring is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Endocrine Disruptor Testing include Charles River Laboratories, Labcorp, Eurofins Scientific, PerkinElmer, Intertek, Smithers, LAUS, Xenometrix, ToxStrategies, Fera Science, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptor Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptor Testing.
The Endocrine Disruptor Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrine Disruptor Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptor Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray
Segment by Type
In Vitro (Cell-based) Testing
In Vivo (Animal) Testing
In Silico (Computational) Modeling
Others
Segment by Application
Environmental Monitoring
Food Safety
Cosmetics and Personal Care Products
Public Health and Disease Prevention
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptor Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptor Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 In Vitro (Cell-based) Testing
1.2.3 In Vivo (Animal) Testing
1.2.4 In Silico (Computational) Modeling
1.2.5 Others
1.3 Market by Application
1.3.1 Global Endocrine Disruptor Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Environmental Monitoring
1.3.3 Food Safety
1.3.4 Cosmetics and Personal Care Products
1.3.5 Public Health and Disease Prevention
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptor Testing Market Perspective (2019-2030)
2.2 Global Endocrine Disruptor Testing Growth Trends by Region
2.2.1 Global Endocrine Disruptor Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Endocrine Disruptor Testing Historic Market Size by Region (2019-2024)
2.2.3 Endocrine Disruptor Testing Forecasted Market Size by Region (2025-2030)
2.3 Endocrine Disruptor Testing Market Dynamics
2.3.1 Endocrine Disruptor Testing Industry Trends
2.3.2 Endocrine Disruptor Testing Market Drivers
2.3.3 Endocrine Disruptor Testing Market Challenges
2.3.4 Endocrine Disruptor Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptor Testing Players by Revenue
3.1.1 Global Top Endocrine Disruptor Testing Players by Revenue (2019-2024)
3.1.2 Global Endocrine Disruptor Testing Revenue Market Share by Players (2019-2024)
3.2 Global Endocrine Disruptor Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptor Testing Revenue
3.4 Global Endocrine Disruptor Testing Market Concentration Ratio
3.4.1 Global Endocrine Disruptor Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptor Testing Revenue in 2023
3.5 Global Key Players of Endocrine Disruptor Testing Head office and Area Served
3.6 Global Key Players of Endocrine Disruptor Testing, Product and Application
3.7 Global Key Players of Endocrine Disruptor Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptor Testing Breakdown Data by Type
4.1 Global Endocrine Disruptor Testing Historic Market Size by Type (2019-2024)
4.2 Global Endocrine Disruptor Testing Forecasted Market Size by Type (2025-2030)
5 Endocrine Disruptor Testing Breakdown Data by Application
5.1 Global Endocrine Disruptor Testing Historic Market Size by Application (2019-2024)
5.2 Global Endocrine Disruptor Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Endocrine Disruptor Testing Market Size (2019-2030)
6.2 North America Endocrine Disruptor Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Endocrine Disruptor Testing Market Size by Country (2019-2024)
6.4 North America Endocrine Disruptor Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptor Testing Market Size (2019-2030)
7.2 Europe Endocrine Disruptor Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Endocrine Disruptor Testing Market Size by Country (2019-2024)
7.4 Europe Endocrine Disruptor Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptor Testing Market Size (2019-2030)
8.2 Asia-Pacific Endocrine Disruptor Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Endocrine Disruptor Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Endocrine Disruptor Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruptor Testing Market Size (2019-2030)
9.2 Latin America Endocrine Disruptor Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Endocrine Disruptor Testing Market Size by Country (2019-2024)
9.4 Latin America Endocrine Disruptor Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptor Testing Market Size (2019-2030)
10.2 Middle East & Africa Endocrine Disruptor Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Endocrine Disruptor Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Endocrine Disruptor Testing Introduction
11.1.4 Charles River Laboratories Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Endocrine Disruptor Testing Introduction
11.2.4 Labcorp Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.2.5 Labcorp Recent Development
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Details
11.3.2 Eurofins Scientific Business Overview
11.3.3 Eurofins Scientific Endocrine Disruptor Testing Introduction
11.3.4 Eurofins Scientific Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.3.5 Eurofins Scientific Recent Development
11.4 PerkinElmer
11.4.1 PerkinElmer Company Details
11.4.2 PerkinElmer Business Overview
11.4.3 PerkinElmer Endocrine Disruptor Testing Introduction
11.4.4 PerkinElmer Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.4.5 PerkinElmer Recent Development
11.5 Intertek
11.5.1 Intertek Company Details
11.5.2 Intertek Business Overview
11.5.3 Intertek Endocrine Disruptor Testing Introduction
11.5.4 Intertek Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.5.5 Intertek Recent Development
11.6 Smithers
11.6.1 Smithers Company Details
11.6.2 Smithers Business Overview
11.6.3 Smithers Endocrine Disruptor Testing Introduction
11.6.4 Smithers Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.6.5 Smithers Recent Development
11.7 LAUS
11.7.1 LAUS Company Details
11.7.2 LAUS Business Overview
11.7.3 LAUS Endocrine Disruptor Testing Introduction
11.7.4 LAUS Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.7.5 LAUS Recent Development
11.8 Xenometrix
11.8.1 Xenometrix Company Details
11.8.2 Xenometrix Business Overview
11.8.3 Xenometrix Endocrine Disruptor Testing Introduction
11.8.4 Xenometrix Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.8.5 Xenometrix Recent Development
11.9 ToxStrategies
11.9.1 ToxStrategies Company Details
11.9.2 ToxStrategies Business Overview
11.9.3 ToxStrategies Endocrine Disruptor Testing Introduction
11.9.4 ToxStrategies Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.9.5 ToxStrategies Recent Development
11.10 Fera Science
11.10.1 Fera Science Company Details
11.10.2 Fera Science Business Overview
11.10.3 Fera Science Endocrine Disruptor Testing Introduction
11.10.4 Fera Science Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.10.5 Fera Science Recent Development
11.11 Compliance Services International
11.11.1 Compliance Services International Company Details
11.11.2 Compliance Services International Business Overview
11.11.3 Compliance Services International Endocrine Disruptor Testing Introduction
11.11.4 Compliance Services International Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.11.5 Compliance Services International Recent Development
11.12 Staphyt
11.12.1 Staphyt Company Details
11.12.2 Staphyt Business Overview
11.12.3 Staphyt Endocrine Disruptor Testing Introduction
11.12.4 Staphyt Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.12.5 Staphyt Recent Development
11.13 Creative Proteomics
11.13.1 Creative Proteomics Company Details
11.13.2 Creative Proteomics Business Overview
11.13.3 Creative Proteomics Endocrine Disruptor Testing Introduction
11.13.4 Creative Proteomics Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.13.5 Creative Proteomics Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptor Testing Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptor Testing Business (2019-2024)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Charles River Laboratories
Labcorp
Eurofins Scientific
PerkinElmer
Intertek
Smithers
LAUS
Xenometrix
ToxStrategies
Fera Science
Compliance Services International
Staphyt
Creative Proteomics
Creative Bioarray

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂